Integra LifeSciences
This article was originally published in The Gray Sheet
Executive Summary
Eight person jury finds that Merck KGaA willfully infringed and induced infringement of four patents licensed to Integra, awarding the Plainsboro, New Jersey firm $15 mil. in damages in California federal court March 17. The patents in question, which Integra licensed from the Burnham Institute of San Diego (No. 4,792,525, No. 4,879,237, No. 5,659,997 and No. 4,789,734) relate to technology involving peptides containing arginine-glycine-aspartic acid sequences or related cell surface receptors. Integra originally filed the suit in 1996. Merck is expected to appeal the decision